tiprankstipranks
Beam Therapeutics (BEAM)
NASDAQ:BEAM
US Market

Beam Therapeutics (BEAM) Technical Analysis

Compare
1,401 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
4Neutral
14Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Beam Therapeutics’s (BEAM) Moving Averages Convergence Divergence (MACD) indicator is -1.41, suggesting Beam Therapeutics is a Buy.
Beam Therapeutics’s (BEAM) 20-Day exponential moving average is 24.43, while Beam Therapeutics’s (BEAM) share price is $22.21, making it a Sell.
Beam Therapeutics’s (BEAM) 50-Day exponential moving average is 25.78, while Beam Therapeutics’s (BEAM) share price is $22.21, making it a Sell.

Beam Therapeutics (BEAM) Pivot Points

Mar 31, 2025, 10:31 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
20.63
21.12
21.65
22.14
22.67
23.16
23.69
Fibonacci
21.12
21.51
21.75
22.14
22.53
22.77
23.16
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Beam Therapeutics (BEAM) Moving Averages

Mar 31, 2025, 10:31 AM
Period
Simple
Exponential
MA5
22.71Sell
22.56Sell
MA10
23.05Sell
23.23Sell
MA20
24.63Sell
24.43Sell
MA50
26.47Sell
25.78Sell
MA100
26.47Sell
26.00Sell
MA200
25.77Sell
25.71Sell
Beam Therapeutics’s (BEAM) 10-Day exponential moving average is 23.23, while Beam Therapeutics’s (BEAM) share price is $22.21, making it a Sell.
Beam Therapeutics’s (BEAM) 100-Day exponential moving average is 26.00, while Beam Therapeutics’s (BEAM) share price is $22.21, making it a Sell.
Beam Therapeutics’s (BEAM) stock price is $22.21 and Beam Therapeutics’s (BEAM) 50-day simple moving average is 26.47, creating a Sell signal.
Beam Therapeutics’s (BEAM) stock price is $22.21 and Beam Therapeutics’s (BEAM) 100-day simple moving average is 26.47, creating a Sell signal.
Beam Therapeutics’s (BEAM) stock price is $22.21 and Beam Therapeutics’s (BEAM) 200-day simple moving average is 25.77, creating a Sell signal.

Beam Therapeutics (BEAM) Technical Indicators

Mar 31, 2025, 10:31 AM
Name
Value
Implied Action
RSI (14)
38.64
Neutral
STOCH (9,6)
14.34
Buy
STOCHRSI (14)
6.49
Buy
MACD (12,26)
-1.41
Buy
ADX (14)
25.97
Neutral
Williams %R
-91.15
Buy
CCI (14)
-99.65
Neutral
ATR (14)
1.90
-
Ultimate Oscillator
43.09
Neutral
ROC
-13.55
Sell
Beam Therapeutics’s (BEAM) Relative Strength Index (RSI) is 38.64, creating a Neutral signal.
Beam Therapeutics’s (BEAM) Trend Strength Indicator (ADX) is 25.97, creating a Neutral signal.
Beam Therapeutics’s (BEAM) Commodity Channel Index (CCI) is -99.65, creating a Neutral signal.
Beam Therapeutics’s (BEAM) Price Rate of Change (ROC) is -13.55, creating a Sell signal.

FAQ

Is BEAM a Buy, Hold, or Sell?
Based on BEAM’s technical indicators, BEAM is a Sell.
    What is BEAM’s RSI (14)?
    BEAM’s RSI (14) is 38.64, which suggests BEAM is a Neutral.
      What is BEAM’s MACD?
      BEAM’s MACD is -1.41, which suggests BEAM is a Buy.
        What is BEAM’s 5-day moving average?
        BEAM’s 5-day moving average is 22.71, which suggests BEAM is a Sell.
          What is BEAM’s 20-day moving average?
          BEAM 20-day moving average is 24.63, which suggests BEAM is a Sell.
            What is BEAM’s 50-day moving average?
            BEAM’s 50-day moving average is 26.47, which suggests BEAM is a Sell.
              What is BEAM’s 200-day moving average?
              BEAM’s 200-day moving average is 25.77, which suggests BEAM is a Sell.
                What is BEAM’s Williams % R (14)?
                BEAM’s Williams % R (14) is -91.15, which suggests BEAM is a Buy.
                  What is BEAM’s CCI (14)?
                  BEAM’s CCI (14) is -99.65, which suggests BEAM is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis